CellaVision AB (STU:C26)
€ 18.64 0.88 (4.95%) Market Cap: 454.18 Mil Enterprise Value: 445.31 Mil PE Ratio: 33.07 PB Ratio: 6.46 GF Score: 99/100

Q4 2020 CellaVision AB Earnings Call Transcript

Feb 04, 2021 / 10:00AM GMT
Release Date Price: €28.24 (-3.75%)
Operator

Hello, and welcome to CellaVision AB year-end report for 2020. (Operator Instructions) Today, I am pleased to present Magnus Blixt, acting CEO. Please go ahead with your meeting.

Magnus Blixt;publ;CFO;Acting CEO
CellaVision AB

()-&

Thank you very much, and welcome, everyone, to this call, where we will go through CellaVision's year-end bulletin and a little bit of background to CellaVision and the financials and activities for Q4. I'm calling in from winter, sunny and cold Lund. Lund is where we have the head office of CellaVision.

My normal role is that I'm CFO for the company, but currently, I'm doubling as acting CEO. For those of you who have called in the past, I'm sure that you recognize that it usually was Zlatko Rihter that presented these reports, but he has left CellaVision in November and is currently heading up Mölnlycke Health Care as CEO for that organization.

CellaVision has appointed a new CEO Simon Ãstergaard. And we are looking forward to welcoming him on board in March.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot